サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1530394

ナットウキナーゼの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2024年～2030年

Nattokinase Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ナットウキナーゼの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月22日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナットウキナーゼ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のナットウキナーゼ市場は2030年までに4,010万米ドルに達し、2024年から2030年までのCAGRは3.1%で成長すると予測されています。

世界のナットウキナーゼ市場を促進している主な要因は、天然で機能的なサプリメントへの動向です。顧客は、合成成分に対する慎重論が高まっているため、好ましくない副作用を伴わずに健康に良い影響を与える天然の代替品を求めています。ナットウキナーゼは天然酵素であるため、サプリメント製造への採用が増加しています。ナットウキナーゼ市場の売上を促進するもう一つの重要な要因は、一般的な健康と幸福を促進するサプリメントへの顧客の傾向の増加です。

単に基本的な栄養補給よりも健康上の利点を提供する食品を求める顧客が増加しています。低炭水化物やグルテンフリーの食事がますます一般的になるにつれて、ナットウキナーゼの需要は大幅に増加しています。多くの顧客は、様々な健康上の理由からグルテンフリーの食事療法を行っており、またセリアック病と診断されています。この市場は拡大しており、ナットウキナーゼはパン作りや料理において小麦粉の代替品として最適です。

ナットウキナーゼは、食品・飲料セクターの機能性食品・飲料に配合されつつあります。これらの製品は、基本的な栄養を提供することに加えて、その他の健康上の特典を提供するために作られています。ナットウキナーゼの使用量と市場浸透率は、通常の食品への組み込みが増加しているため、増加すると予想されます。ナットウキナーゼはさらに、アンチエイジングや肌の健康に役立つ可能性があるため、化粧品事業にも利用されています。この酵素は、血流を促進し、血栓を破壊する能力があるため、スキンケア処方の有用な成分です。

2023年には、栄養補助食品用途が市場で最も高いシェアを占めました。健康とウェルネスを重視する傾向が強まり、健康をサポートするための自然で効果的なサプリメントに対する消費者の関心が高まっています。機能性食品と栄養補助食品を包含する栄養補助食品は、その安全性と健康上の利点の認識からますます支持されるようになっています。世界的に予防ヘルスケアへのシフトが進んでおり、消費者は単に反応的に病気を治療するのではなく、病気を予防する手段を優先しています。ナットウキナーゼは心血管に良いことで知られ、そのため栄養補助食品の生産で脚光を浴び、市場拡大に大きく貢献しています。

ナットウキナーゼ市場の主要プレーヤーには、株式会社日本バイオサイエンス研究所、Novonesis Group（MenaquinGold）、Contek Life Science Co.各社は市場シェアを拡大するため、世界展開、提携、買収・合併、新製品の開発・上市など、さまざまな手段を講じています。

ナットウキナーゼ市場レポートハイライト

  • 用途別では、医薬品分野が2024年から2030年にかけてCAGR 3.6%の成長が見込まれます。慢性疾患、特に心血管疾患の有病率の増加により、効率的な治療に対する需要が急増しています。この動向はナットウキナーゼ市場を前進させる重要な要因です。
  • アジア太平洋地域は2024年から2030年にかけてCAGR 3.5%で成長すると予想されます。同地域の消費者の間で、心血管と健康全般の重要性に関する意識が高まっていることが、市場成長の原動力となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ナットウキナーゼ市場の変数、動向、範囲

  • 市場イントロダクション
  • 業界バリューチェーン分析
    • 利益率分析
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 業界の課題
    • 業界の機会
  • 業界分析- ポーターのファイブフォース分析
  • 市場参入戦略

第4章 ナットウキナーゼ市場：用途別推定・動向分析

  • 栄養補助食品
  • 食品添加物
  • 製薬
  • その他

第5章 ナットウキナーゼ市場：地域別推定・動向分析

  • 地域別変動分析と市場シェア、2023年と2030年
  • 北米
    • 市場推計・予測、2018年-2030年
    • 米国
    • カナダ
  • 欧州
    • 市場推計・予測、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
  • アジア太平洋
    • 市場推計・予測、2018年-2030年
    • 中国
    • 日本
    • オーストラリア
    • 韓国
  • 中南米
    • 市場推計・予測、2018年-2030年
  • 中東・アフリカ
    • 市場推計・予測、2018年-2030年

第6章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 参入企業の概要
  • 財務実績
  • 製品ベンチマーク
  • 企業市場シェア分析、2023年（％）
  • 企業ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル
  • Japan Bio Science Laboratory Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Novonesis Group（MenaquinGold）
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Creative Enzymes
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Weidan Biotechnology Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • BIO-CAT
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Bioven Ingredients
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Eiffel Biotech
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Daiwa Pharmaceutical Co. Ltd.
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Contek Life Science Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Sungen Bioscience Co., Ltd
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
図表

List of Tables

  • 1. Nattokinase market - Key market driver analysis
  • 2. Nattokinase market - Key market restraint analysis
  • 3. Nattokinase market estimates and forecast for nutraceuticals, 2018 - 2030 (USD Millions)
  • 4. Nattokinase market estimates and forecast for food additives, 2018 - 2030 (USD Millions)
  • 5. Nattokinase market estimates and forecast for pharmaceuticals, 2018 - 2030 (USD Millions)
  • 6. Nattokinase market estimates and forecast for other applications, 2018 - 2030 (USD Millions)
  • 7. North America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 8. North America nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 9. U.S. macro-economic outlay
  • 10. U.S. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 11. U.S. nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 12. Canada macro-economic outlay
  • 13. Canada nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 14. Canada nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 15. Europe nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 16. Europe nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 17. Germany macro-economic outlay
  • 18. Germany nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 19. U.K. macro-economic outlay
  • 20. U.K. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 21. U.K. nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 22. Spain macro-economic outlay
  • 23. Spain nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 24. Spain nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 25. Italy macro-economic outlay
  • 26. Italy nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 27. Italy nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 28. France macro-economic outlay
  • 29. France nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 30. France nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 31. Asia Pacific nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 32. Asia Pacific nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 33. China macro-economic outlay
  • 34. China nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 35. China nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 36. Australia macro-economic outlay
  • 37. Asutralia nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 38. Australia nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 39. Japan macro-economic outlay
  • 40. Japan nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 41. Japan nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 42. South Korea macro-economic outlay
  • 43. South Korea nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 44. South Korea nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 45. Central & South America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 46. Central & South America nattokinase market revenue estimates and forecast, by source, 2018 - 2030 (USD Millions)
  • 47. Central & South America nattokinase market revenue estimates and forecast, by form, 2018 - 2030 (USD Millions)
  • 48. Central & South America nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
  • 49. Middle East & Africa nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 50. Middle East & Africa nattokinase market revenue estimates and forecast, by source, 2018 - 2030 (USD Millions)
  • 51. Middle East & Africa nattokinase market revenue estimates and forecast, by form, 2018 - 2030 (USD Millions)
  • 52. Middle East & Africa nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)

List of Figures

  • 1. Nattokinase market snapshot
  • 2. Nattokinase market segmentation & scope
  • 3. Nattokinase market penetration & growth prospect mapping
  • 4. Nattokinase market value chain analysis
  • 5. Nattokinase market dynamics
  • 6. Nattokinase market Porter's Five Forces analysis
  • 7. Nattokinase market: Application movement analysis, 2023 & 2030 (%)
  • 8. Nattokinase in animal feed market estimates and forecast, 2018 - 2030 (USD Millions)
  • 9. Nattokinase market estimates and forecast for nutraceuticals, 2018 - 2030 (USD Millions)
  • 10. Nattokinase market estimates and forecast for food additives, 2018 - 2030 (USD Millions)
  • 11. Nattokinase market estimates and forecast for pharmaceuticals, 2018 - 2030 (USD Millions)
  • 12. Nattokinase market estimates and forecast for other applications, 2018 - 2030 (USD Millions)
  • 13. Nattokinase market: Regional movement analysis, 2023 & 2030 (%)
  • 14. North America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 15. U.S. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 16. Canada nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 17. Europe nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 18. Germany nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 19. U.K. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 20. Spain nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 21. Italy nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 22. France nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 23. Asia Pacific nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 24. China nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 25. Australia nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 26. Japan nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 27. South Korea nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 28. Central & South America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
  • 29. Middle East & Africa nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
目次
Product Code: GVR-4-68040-367-2

Nattokinase Market Growth & Trends:

The global nattokinase market is expected to reach USD 40.1 million by 2030 and growing at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. A major factor propelling the nattokinase market worldwide is the trend towards natural and functional supplements. Customers are looking for natural substitutes that have positive health impacts without unfavorable side effects due to growing cautious of synthetic ingredients. Nattokinase is a natural enzyme owing to which it is adoption is rising in supplement manufacturing. Another significant factor propelling the nattokinase market's sales is the growing customer inclination for supplements that promote general health and wellbeing.

A rising number of customers are looking for foods that offer health advantages over just basic nourishment. The demand for nattokinase has increased significantly as low-carb and gluten-free diets have become more and more popular. Many customers follow gluten-free diets for various health-related reasons, or they have been diagnosed with celiac disease. This market is expanding, and nattokinase is a great alternative to wheat flour in baking and cooking. Almond powder has also become more popular due to the ketogenic diet, which places a strong emphasis on consuming large amounts of fat and few carbohydrates. It is a mainstay in recipes that are keto-friendly due to its low carbohydrate level.

Nattokinase is being included in functional foods and beverages by the food and beverage sector. In addition to providing basic nutrition, these products are made to offer additional health benefits. the usage and market penetration of nattokinase is anticipated to increase owing to its rising incorporation into regular food products. Nattokinase is further utilized in the cosmetics business due to its possible anti-aging and skin health advantages. The enzyme is a useful component in skincare formulas owing to its capacity to promote blood flow and break blood clots, both of which can improve skin health.

Nutraceuticals application held the highest share of the market in 2023. The growing emphasis on health and wellness has driven a heightened consumer interest in natural and effective supplements to support well-being. Nutraceuticals, encompassing functional foods and dietary supplements, are increasingly favored for their perceived safety and health benefits. There is a global shift towards preventive healthcare, with consumers prioritizing measures to prevent diseases rather than merely treating them reactively. Nattokinase, renowned for its cardiovascular benefits, has thus gained prominence in the production of dietary supplements, contributing significantly to market expansion.

Major players in the nattokinase market include Japan Bio Science Laboratory Co., Ltd., Novonesis Group (MenaquinGold), Contek Life Science Co., Ltd., and others. Companies are taking various steps such as global expansion, partnerships, acquisitions & mergers, development & launch of new products, and others to gain more share of the market.

Nattokinase Market Report Highlights:

  • Based on application, pharmaceuticals segment is expected to grow at a CAGR of 3.6% from 2024 to 2030. The increasing prevalence of chronic diseases, notably cardiovascular conditions, has surged the demand for efficient treatments. This trend is a significant driver propelling the nattokinase market forward.
  • Asia Pacific is expected to grow at a CAGR of 3.5% from 2024 to 2030. The growing awareness regarding the significance of cardiovascular and overall health among consumers in the region is driving the market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Application Outlook
  • 2.3. Regional Outlook
  • 2.4. Competitive Insights

Chapter 3. Nattokinase Market Variables, Trends & Scope

  • 3.1. Market Introduction
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Industry Challenges
    • 3.3.4. Industry Opportunities
  • 3.4. Industry Analysis - Porter's Five Force Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Nattokinase Market: Application Estimates & Trend Analysis

  • 4.1. Nutraceuticals
    • 4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.2. Food Additives
    • 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3. Pharmaceutical
    • 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Nattokinase Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Movement Analysis & Market Share, 2023 & 2030
  • 5.2. North America
    • 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key country dynamics
      • 5.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key country dynamics
      • 5.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.5. Spain
      • 5.3.5.1. Key country dynamics
      • 5.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.6. Italy
      • 5.3.6.1. Key country dynamics
      • 5.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.2. China
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Japan
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.4. Australia
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.5. South Korea
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Central & South America
    • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Competitive Analysis

  • 6.1. Recent developments & impact analysis, by key market participants
  • 6.2. Company Categorization
  • 6.3. Participant's Overview
  • 6.4. Financial Performance
  • 6.5. Product Benchmarking
  • 6.6. Company Market Share Analysis, 2023 (%)
  • 6.7. Company Heat Map Analysis
  • 6.8. Strategy Mapping
  • 6.9. Company Profiles
  • 6.10. Japan Bio Science Laboratory Co., Ltd.
    • 6.10.1. Company Overview
    • 6.10.2. Financial Performance
    • 6.10.3. Product Benchmarking
    • 6.10.4. Strategic Initiatives
  • 6.11. Novonesis Group (MenaquinGold)
    • 6.11.1. Company Overview
    • 6.11.2. Financial Performance
    • 6.11.3. Product Benchmarking
    • 6.11.4. Strategic Initiatives
  • 6.12. Creative Enzymes
    • 6.12.1. Company Overview
    • 6.12.2. Financial Performance
    • 6.12.3. Product Benchmarking
    • 6.12.4. Strategic Initiatives
  • 6.13. Weidan Biotechnology Co., Ltd.
    • 6.13.1. Company Overview
    • 6.13.2. Financial Performance
    • 6.13.3. Product Benchmarking
    • 6.13.4. Strategic Initiatives
  • 6.14. BIO-CAT
    • 6.14.1. Company Overview
    • 6.14.2. Financial Performance
    • 6.14.3. Product Benchmarking
    • 6.14.4. Strategic Initiatives
  • 6.15. Bioven Ingredients
    • 6.15.1. Company Overview
    • 6.15.2. Financial Performance
    • 6.15.3. Product Benchmarking
    • 6.15.4. Strategic Initiatives
  • 6.16. Eiffel Biotech
    • 6.16.1. Company Overview
    • 6.16.2. Financial Performance
    • 6.16.3. Product Benchmarking
    • 6.16.4. Strategic Initiatives
  • 6.17. Daiwa Pharmaceutical Co. Ltd.
    • 6.17.1. Company Overview
    • 6.17.2. Financial Performance
    • 6.17.3. Product Benchmarking
    • 6.17.4. Strategic Initiatives
  • 6.18. Contek Life Science Co., Ltd.
    • 6.18.1. Company Overview
    • 6.18.2. Financial Performance
    • 6.18.3. Product Benchmarking
    • 6.18.4. Strategic Initiatives
  • 6.19. Sungen Bioscience Co., Ltd
    • 6.19.1. Company Overview
    • 6.19.2. Financial Performance
    • 6.19.3. Product Benchmarking
    • 6.19.4. Strategic Initiatives